Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation

Abroad (travel likely)RecruitingPHASE3

Conditions

Chronic Kidney Diseases · Atrial Fibrillation · Stroke · Intracerebral Hemorrhage · Major Bleed · Cardiovascular Complication · Death · Kidney Transplant; Complications · Thromboses, Venous

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Helsingfors University hospital, Helsinki, Finland

    Contact: Study coordinator (Helsingfors U hospital, MD)
    Contact: Principal Investigator (Patrik Finne, Prof)
  • Tampere hospital, Tampere, Finland

    Contact: Study coordinator (Satu Mäkelä, MD)
    Contact: Principal Investigator (Satu Mäkelä, MD)
  • Turku hospital, Turku, Finland

    Contact: Study coordinator (Tapio Hellman, MD)
    Contact: Principal Investigator (Tapio Hellman, MD)
  • Landspitali, the National University hospital of Iceland, Reykjavik, Iceland

    Contact: Study coordinator (Sunna Snaedal, MD, PhD)
    Contact: Study coordinator (Asta Jonasdottir, MD, PhD)
    Contact: Principal Investigator (Sunna Snaedal, MD)
    Asta Jonasdottir, MD (Sub-investigator)
  • Oslo Akershus, Oslo, Norway

    Contact: Study coordinator (Kristyna Parker, MD)
    Contact: Principal Investigator (Kristyna Parker, MD)
  • Oslo Universitetssjukhus Ullevål, Oslo, Norway

    Contact: Study coordinator (Benedict Ronning, PhD) · uxrnnb@ous-hf.no
    Contact: Principal Investigator (Aud Hoieggen, MD PhD)
  • Stavanger hospital, Stavanger, Norway

    Contact: Study coordinator (Eva Staal)
    Contact: Principal Investigator (Lasse Goransson, Prof)
    Eva Staal, MD (Sub-investigator)
  • Tromsö hospital, Tromsø, Norway

    Contact: Study coordinator (Ludvig Rinde) · Ludvig.Rinde@unn.no
    Contact: Principal Investigator (Marit Solbu, MD)
  • Vestfold hospital, Tønsberg, Norway

  • Falun hospital, Falun, Dalarna County, Sweden

    Contact: Study coordinator (Anna Sahlander, MD)
    Contact: Principal Investigator (Anna Sahlander, MD)
    Omar Ahmed Hamad, MD (Sub-investigator)
  • Östersund hospital, Östersund, Jämtland County, Sweden

    Contact: Study coordinator (Jan Flesche, MD)
    Contact: Principal Investigator (Jan Flesche, MD)
  • Lasarettet i Falun, Falun, Region Dalarna, Sweden

    Contact: Study coordinator (Anna Sahlander, MD)
    Contact: Principal Investigator (Anna Sahlander, MD)
  • Mora sjukhus, Mora, Region Dalarna, Sweden

    Contact: Study coordinator (Hans Furuland, MD)
    Contact: Principal Investigator (Hans Furuland, PhD)
  • Länssjukhuset Kalmar, Kalmar, Region Kalmar Län, Sweden

    Contact: Study coordinator (Nikolaos Rigas, MD)
    Contact: Principal Investigator (Nikolaos Rigas, MD)
  • Kalix hospital, Kalix, Region Norrbotten, Sweden

    Contact: Study coordinator (Nils Sundberg, MD)
    Contact: Principal Investigator (Nils Sundberg, MD)
  • Skånes University hospital Lund, Lund, Region Skåne, Sweden

    Contact: Study coordinator (Mårten Segelmark, Prof)
    Contact: Principal Investigator (Mårten Segelmark, Prof)
    Mikael Gottsäter, MD (Sub-investigator)
  • Skånes University hospital Malmö, Malmö, Region Skåne, Sweden

    Contact: Study coordinator (Anders Christenssen, Prof)
    Contact: Principal Investigator (Anders Christenssen, Prof)
    Mikael Gottsäter, MD (Sub-investigator)
  • Norrland University hospital Umeå, Umeå, Region Västerbotten, Sweden

    Contact: Study coordinator (Andreas Jonsson, MD)
    Contact: Principal Investigator (Andreas Jonsson, MD)
    Björn Runesson, MD (Sub-investigator)
  • Sundsvall, Sundsvall, Region Västernorrland, Sweden

    Contact: Study coordinator (Frida Welander, MD)
    Contact: Principal Investigator (Frida Welander, MD)
  • Västmanlands sjukhus Västerås, Västerås, Region Västmanland, Sweden

    Contact: Study coordinator (Josefin Mörtberg, MD)
    Contact: Principal Investigator (Josefin Mörtberg, MD)
  • Borås sjukhus, Borås, Region Västra Götaland, Sweden

    Contact: Study coordinator (Achim Barth, MD)
    Contact: Principal Investigator (Achim Barth)
  • Sahlgrenska University hospital, Gothenburg, Region Västra Götaland, Sweden

    Contact: Study coordinator (Gregor Guron, Prof)
    Contact: Principal Investigator (Gregor Guron, Prof)
  • Skaraborg hospital Skövde, Skövde, Region Västra Götaland, Sweden

    Contact: Study coordinator (Anna Wärme, MD)
    Contact: Principal Investigator (Anna Wärme, MD)
    Hanna Liljebäck, MD (Sub-investigator)
  • University hospital Örebro, Örebro, Region Örebro Län, Sweden

    Contact: Study coordinator (Piotr Jacuszewski, MD)
    Contact: Principal Investigator (Piotr Jacuszewski, MD)
  • Linköping University hospital, Linköping, Region Östergötland, Sweden

    Contact: Study coordinator (Fredrik Uhlin, RN)
    Contact: Principal Investigator (Maria Weiner, MD)
  • Länssjukhuset Ryhov, Jönköping, Sweden

    Contact: Study coordinator (Maria Stendahl, PhD)
    Contact: Principal Investigator (Maria Stendahl, MD PhD)
  • Karlshamns sjukhus, Karlshamn, Sweden

    Contact: Study coordinator (Jonas Andersson, MD) · jonas.andersson@regionblekinge.se
    Contact: Principal Investigator (Julia Schönknecht, MD)
  • Karlstad Central hospital, Karlstad, Sweden

    Contact: Study coordinator (Johan Isaksson, MD)
  • Norrköpings sjukhus, Norrköping, Sweden

    Contact: Study coordinator (Fredrik Sundelin, MD)
    Contact: Principal Investigator (Fredrik Sundelin, MD)
  • Skellefteå hospital, Skellefteå, Sweden

    Contact: Study coordinator (Cecilia Johansson, MD, PhD)
    Contact: Principal Investigator (Cecilia Johansson, MD, PhD)
  • Karolinska Universitetssjukhuset, Stockholm, Sweden

    Contact: Study coordinator (Marie Evans, PhD) · marie.evans@regionstockholm.se · +4612382550
    Olof Heimburger, PhD (Sub-investigator)
    Contact: Principal Investigator (Marie Evans, PhD)
  • Danderyd sjukhus AB, Stockholm, Sweden

    Contact: Study coordinator (Karin Bergen, MD)
    Contact: Principal Investigator (Sigrid Lundberg, MD PhD)
    Fredrik Dunér, MD PhD (Sub-investigator)
    Karin Bergen, MD (Sub-investigator)
  • Akdemiska sjukhuset Uppsala, Uppsala, Sweden

    Contact: Study coordinator (Kerstin Martala, RN)
    Contact: Principal Investigator (Maria Eriksson Svensson, Prof)
    Hans Furuland, MD (Sub-investigator)
  • Varberg hospital, Varberg, Sweden

    Contact: Study coordinator (Oscar Bratt, MD)
    Contact: Principal Investigator (Oscar Bratt, MD)
Study leads
  • Marie Evans, Ass Prof

    Principal Investigator

    Karolinska University Hospital

  • Maria Svensson, Prof

    Study Chair

    Uppsala University